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In medical research animal models have demonstrated
their value in elucidating (1) mechanisms of disease,
(2) factors implicated in morbidity and mortality of the
disease, and (3) new therapeutic avenues to treat the
disease.Foracuteaswellaschronicdiseases,modelsfor
translationalmedicinehavebeendevelopedandapplied
with great beneﬁt. The use of experimental animals
should comply with both the Animal Welfare Act and
theGuidefortheCareandUseofLaboratoryAnimalsin
which researchers demonstrate that they have carefully
considered the three R’s of animal testing alternatives:
(1) Reduction of the numbers of animals used,
(2) Reﬁnement of techniques and procedures to reduce
pain and distress, and (3) Replacement of animals by
other models than living animals. Particularly the
condition to reduce the number of animals necessary
to test a hypothesis is difﬁcult to meet, but the use of
animal models and techniques that allow longitudinal
measurements from the same animals may lead to a
wealth of data from a limited number of animals. In
translational research of cardiovascular disease the use
of echocardiography allows longitudinal studies of
natural history and therapeutic success.
In the current issue of the International Journal of
Cardiovascular Imaging, Koskenvuo and coworkers
[1] used echocardiography in a rat model of monocro-
taline-induced pulmonary arterial hypertension
(PAH). The authors evaluated whether invasive mea-
surements of blood pressures, vascular resistances,
right ventricular (RV) wall thickness and RV cavity
size could be replaced accurately by corresponding
echocardiographic measurements. The authors suc-
ceeded to acquire echocardiographic images that
produced parameters of PAH with low (\10%) intra-
observer and low inter-observer variability, except for
tissue Doppler derived isovolumetric relaxation time
of the RV (IVRT’) having an interobserver variability
of 22.2%. Regarding diagnostic performance of echo-
cardiographic parameters to detect PAH, i.e. a mean
pulmonary arterial pressure [25 mmHg, the authors
found a sensitivity of 86.4%, a speciﬁcity of 97.6%, a
positive predictive value of 92.3%, and a negative
predictive value of 93.8%. At day 21, noninvasive
assessment of PAH demonstrated large differences
between invasively measured systolic PAP and echo-
cardiographically assessed systolic PAP (39.5 ± 15.5
and 66.4 ± 18.8 mmHg, respectively) and between
invasively measured total pulmonary vascular resis-
tance (TPVR) and echocardiographically assessed
TPVR (3.5 ± 2.3 and 7.7 ± 2.8 10
4*dyn.s.cm
-5).
The authors held these large differences responsible
to the absence of signiﬁcant tricuspid valve regurgita-
tion(TR)jetinseveralratswithdevelopingPAH.This
seems a very likely explanation as at day 35 both
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approached echocardiographically assessed systolic
PAP and TPVR much better. Of note, TPVR has not
previously been studied in rodents using echocardiog-
raphy. It was concluded that the use of non-invasive
parameters may replace invasive measurements in
detecting successful disease induction and to comple-
mentinvasivedataintheevaluationofPAHseverityin
a rat model.
The difﬁculty of performing invasive measure-
ments in animals with advanced PAH is an important
limitation of all invasive parameters and underscores
the importance of innovative noninvasive measure-
ments. The highly vulnerable status of the RV and
more generally of the heart in rats with severe PAH
often hampers extensive characterization of RV
function with the pressure-conductance catheter as
we have experienced ourselves [2–4]. As a result,
echocardiography may have a speciﬁc new role in
evaluating PAH. The main disadvantage of electro-
cardiographic assessment of PAH is to accurately
assess the functional characteristics of RV. In the
present study, in 13 out of 75 (17%) studies no
adequate echocardiographic RV measurements could
be performed. Generally, assessment of the RV is
cumbersome by echocardiography due to limited
acoustic window and the abnormal shape of the RV
[5–16]. These limitations might be to a certain extent
overcome by using transesophageal or 3D-echocar-
diography [17–21], but magnetic resonance imaging
often provides a better visualization of the RV,
allowing improved quantiﬁcation [22–33].
In the current study [1], however, it was clearly
shown that employment of echocardiography in
animals allows assessment of in vivo RV function
without additional harm to the animals. In addition,
echocardiography enabled longitudinal measure-
ments thereby lowering the number of animals
included in the study. Knowledge and experience in
echocardiography of small rodents, so elegantly
shown by the authors, is hard to acquire but this is
certainly the way to go in future translational research
of chronic cardiovascular diseases.
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